These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 18270990)

  • 41. Analytics with engineered bacterial bioreporter strains and systems.
    van der Meer JR
    Curr Opin Biotechnol; 2006 Feb; 17(1):1-3. PubMed ID: 16417997
    [No Abstract]   [Full Text] [Related]  

  • 42. Pyrene modification leads to increased catalytic activity in minimal hammerhead ribozymes.
    Looser V; Langenegger SM; Häner R; Hartig JS
    Chem Commun (Camb); 2007 Nov; (42):4357-9. PubMed ID: 17957285
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Illuminating the detection chain of bacterial bioreporters.
    van der Meer JR; Tropel D; Jaspers M
    Environ Microbiol; 2004 Oct; 6(10):1005-20. PubMed ID: 15344926
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Concerted effects of two activator modules on the group I ribozyme reaction.
    Ikawa Y; Shiohara T; Ohuchi S; Inoue T
    J Biochem; 2009 Apr; 145(4):429-35. PubMed ID: 19122204
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Programmed drug-dependent ribosome stalling.
    Ramu H; Mankin A; Vazquez-Laslop N
    Mol Microbiol; 2009 Feb; 71(4):811-24. PubMed ID: 19170872
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sequence-dependent folding and unfolding of ligand-bound purine riboswitches.
    Prychyna O; Dahabieh MS; Chao J; O'Neill MA
    Biopolymers; 2009 Nov; 91(11):953-65. PubMed ID: 19603494
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A rate-limiting conformational step in the catalytic pathway of the glmS ribozyme.
    Brooks KM; Hampel KJ
    Biochemistry; 2009 Jun; 48(24):5669-78. PubMed ID: 19449899
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Meeting report: Regulating with RNA in Bacteria 2013.
    Vogel J; Gottesman S; Belasco J; Narberhaus F
    RNA Biol; 2014; 11(5):403-12. PubMed ID: 24922515
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Adenine, a hairpin ribozyme cofactor--high-pressure and competition studies.
    Ztouti M; Kaddour H; Miralles F; Simian C; Vergne J; Hervé G; Maurel MC
    FEBS J; 2009 May; 276(9):2574-88. PubMed ID: 19476496
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In vitro and in vivo production and purification of circular RNA aptamer.
    Umekage S; Kikuchi Y
    J Biotechnol; 2009 Feb; 139(4):265-72. PubMed ID: 19138712
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Insights into functional modulation of catalytic RNA activity.
    Vourekas A; Stamatopoulou V; Toumpeki C; Tsitlaidou M; Drainas D
    IUBMB Life; 2008 Oct; 60(10):669-83. PubMed ID: 18636557
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Transcriptome complexity in a genome-reduced bacterium.
    Güell M; van Noort V; Yus E; Chen WH; Leigh-Bell J; Michalodimitrakis K; Yamada T; Arumugam M; Doerks T; Kühner S; Rode M; Suyama M; Schmidt S; Gavin AC; Bork P; Serrano L
    Science; 2009 Nov; 326(5957):1268-71. PubMed ID: 19965477
    [TBL] [Abstract][Full Text] [Related]  

  • 53. How RNA closes a Diel.
    Pitt JN; Ferré-D'Amaré AR
    Nat Struct Mol Biol; 2005 Mar; 12(3):206-8. PubMed ID: 15744318
    [No Abstract]   [Full Text] [Related]  

  • 54. Coordinated control of a designed trans-acting ligase ribozyme by a loop-receptor interaction.
    Matsumura S; Ohmori R; Saito H; Ikawa Y; Inoue T
    FEBS Lett; 2009 Sep; 583(17):2819-26. PubMed ID: 19631647
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Magic spot: (p) ppGpp.
    Wu J; Xie J
    J Cell Physiol; 2009 Aug; 220(2):297-302. PubMed ID: 19391118
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impact of genome reduction on bacterial metabolism and its regulation.
    Yus E; Maier T; Michalodimitrakis K; van Noort V; Yamada T; Chen WH; Wodke JA; Güell M; Martínez S; Bourgeois R; Kühner S; Raineri E; Letunic I; Kalinina OV; Rode M; Herrmann R; Gutiérrez-Gallego R; Russell RB; Gavin AC; Bork P; Serrano L
    Science; 2009 Nov; 326(5957):1263-8. PubMed ID: 19965476
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Interactions of recombinant HMGB proteins with branched RNA substrates.
    Bell AJ; Chauhan S; Woodson SA; Kallenbach NR
    Biochem Biophys Res Commun; 2008 Dec; 377(1):262-7. PubMed ID: 18845125
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Development and application of in vivo expression technology (IVET) for analysing microbial gene expression in complex environments.
    Jackson RW; Giddens SR
    Infect Disord Drug Targets; 2006 Sep; 6(3):207-40. PubMed ID: 16918484
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [A promising strategy to generate artificial RNA catalysts: the marriage of de novo design and directed evolution].
    Ikawa Y
    Tanpakushitsu Kakusan Koso; 2006 Jul; 51(8):950-7. PubMed ID: 16838669
    [No Abstract]   [Full Text] [Related]  

  • 60. RNAs in extreme environments.
    Torchet C; Maurel MC
    Chem Biodivers; 2007 Sep; 4(9):1957-71. PubMed ID: 17886853
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.